Skip to main
VTR
VTR logo

Ventas (VTR) Stock Forecast & Price Target

Ventas (VTR) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 64%
Hold 21%
Sell 0%
Strong Sell 0%

Bulls say

Ventas boasts a diversified healthcare portfolio of nearly 1,400 properties across various sectors, including senior housing and medical offices, which establishes a solid foundation for its revenue generation and risk mitigation. The firm's strategic geographic exposure spans mature healthcare markets in both the United States and internationally, including Canada and the United Kingdom, thereby enhancing its resilience against market fluctuations. Furthermore, despite the competitive landscape for healthcare properties, Ventas’s focus on monitoring and optimizing its portfolio allows for proactive management of tenant relations and potential impacts on occupancy and rent levels.

Bears say

The negative outlook on Ventas's stock is primarily attributed to potential reductions in Medicare and Medicaid reimbursements, which could weaken rent coverage ratios and consequently lead to rent restructuring or reductions. Additionally, while Ventas maintains a diversified portfolio, it has significant revenue exposure to individual tenants exceeding 5%, raising concerns about its financial stability amid reimbursement rate declines. Furthermore, the healthcare REIT sector's reliance on bond-like cash flows presents challenges in a rising interest rate environment, potentially hindering access to capital markets critical for growth.

Ventas (VTR) has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 64% recommend Buy, 21% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ventas and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ventas (VTR) Forecast

Analysts have given Ventas (VTR) a Buy based on their latest research and market trends.

According to 14 analysts, Ventas (VTR) has a Buy consensus rating as of Nov 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $77.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $77.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ventas (VTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.